Leyden Labs (private company)
See something wrong or missing? Let us know
Offices:Amsterdam
Industry:BiotechHealth services
Business model:B2B
Leyden Laboratories aims to protect against a broad range of viruses via a platform used to target commonalities of viral families to protect against many viruses simultaneously as opposed to vaccines that typically protect against a specific virus variant.
Investors:
we tracked 9 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 258.84M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Leyden Labs
| Name | Criteria | |
|---|---|---|
 |
Atai Life Sciences
67%
|
|
 |
Mogrify
67%
|
|
|
Causaly
67%
|
|
|
bit.bio
67%
|
|
 |
Xenothera
63%
|
|
|
Sense Biodetection
63%
|
|
|
Sano Genetics
62%
|
|
|
Clustermarket
62%
|
|
 |
Cinclus Pharma
60%
|
|
 |
Mentis Cura
60%
|
|
Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Ireland
Italy
Portugal
Spain